drugset / Trial / NCT05729386
A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and pharmacokinetics of oral administration of GC2129A in fed conditions to healthy adult volunteers.
Timeline
- Start
- 2023-02-06
- Primary completion
- 2023-04-17
- Completion
- 2023-04-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GC2129A | Unknown | — | Oral |
| Subject | Linagliptin | Unknown | 5 mg | — |
| Subject | Metformin | Small molecule | 1000 mg | — |
Indications
No indication recorded.